ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

Olympus Corp.

Business Summary

Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2019 JPYUSD
Gross Profit479,699M4,325.71M
Operating income72,171M650.80M
Income before tax20,117M181.40M
Net income8,147M73.46M
Diluted EPS5.960.05
Dividends Per Share7.500.06
Total Assets932,030M8,420.56M
Total liabilities489,643M4,423.75M
Total equity441,193M3,986.02M
Operating cash flow66,943M603.66M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 764,671M 804,578M 740,557M 786,497M 793,862M
Gross Profit 489,040M 534,482M 447,567M 481,111M 479,699M
Operating income 91,712M 104,464M 80,789M 84,282M 72,171M
Income before tax 8,934M 70,800M 62,481M 76,665M 20,117M
Net income -8,737M 62,594M 42,783M 57,064M 8,147M
EBITDA 299,947M 154,243M 135,079M 137,195M 130,840M
Diluted EPS -6.38 45.71 31.24 41.69 5.96
Dividends Per Share 2.50 4.25 7 7 7.50
Total Assets 1,081.55B 1,000.61B 960,032M 978,663M 932,030M
Total liabilities 724,297M 616,331M 563,804M 534,404M 489,643M
Total equity 355,722M 382,787M 394,751M 442,793M 441,193M
Operating cash flow 66,811M 48,621M 102,052M 95,146M 66,943M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 6,960.63M 6,700.11M 6,838.80M 7,096.27M 7,158.70M
Gross Profit 4,451.62M 4,450.89M 4,133.13M 4,340.88M 4,325.71M
Operating income 834.83M 869.92M 746.06M 760.44M 650.80M
Income before tax 81.32M 589.58M 576.99M 691.71M 181.40M
Net income -79.53M 521.25M 395.08M 514.86M 73.46M
EBITDA 2,730.35M 1,284.45M 1,247.41M 1,237.85M 1,179.85M
Diluted EPS -0.05 0.38 0.28 0.37 0.05
Dividends Per Share 0.02 0.03 0.06 0.06 0.06
Total Assets 9,018.56M 8,902.65M 8,615.56M 9,202.28M 8,420.56M
Total liabilities 6,039.58M 5,483.61M 5,059.71M 5,024.95M 4,423.75M
Total equity 2,966.20M 3,405.72M 3,542.59M 4,163.54M 3,986.02M
Operating cash flow 608.16M 404.89M 942.41M 858.46M 603.66M

Valuation Measures

Mar 2019
Operating margin9.09%
Profit margin1.02%

Key executives

  • President, CEO & Director: Yasuo Takeuchi
  • Chief Operating Officer & Director: Akihiro Taguchi
  • Chief Financial Officer: Yasushi Sakai
  • Director & Chief Technology Officer: Haruo Ogawa
  • Global Chief Compliance Officer: Caroline West


  • Olympus Corp. (6.2%)
  • ValueAct Capital Management LP (5.0%)
  • Massachusetts Financial Services Co. (5.0%)
  • Nomura Asset Management Co., Ltd. (4.8%)
  • Nippon Life Insurance Co. (3.8%)
  • Sumitomo Mitsui Banking Pension Fund (3.3%)
  • Mitsubishi UFJ Financial Group, Inc. (3.2%)
  • Nikko Asset Management Co., Ltd. (2.7%)
  • BlackRock Fund Advisors (2.5%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.3%)

Contact Details

  • Website:
  • Address: Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Tokyo, 163-0914, Japan
  • Phone: +81.3.3340.2111

Related Companies

  • Olympus Restricted Stock Compensation Plan
  • YuanLi Instrument Co. Ltd.
  • Olympus Service Facility Portugal - Tecnologias Opticas e Digi
  • Olympus Korea Service Co., Ltd.
  • Olympus Optical do Brasil Ltda.
  • Olympus Moscow LLC
  • Olympus Europa SE & Co. KG
  • Olympus Europa Property Management GmbH
  • Olympus doo za trgovinu
  • Olympus Corporation of the Americas Pennsylvania
  • Olympus doo Beograd
  • Olympus Czech Group sro
  • Olympus Slovenija Trgovina doo
  • Olympus Iberia SAU
  • Olympus Communications Technology of America, Inc.
  • Vichen B&I Co., Ltd.
  • Gyrus ACMI, Inc.
  • Olympus Estonia OU
  • Olympus (Thailand) Co. Ltd.
  • Olympus Australia Pty Ltd.
  • Olympus Europa Management SE
  • Olympus BH doo
  • Olympus Medical Systems Vietnam Co. Ltd.
  • Olympus Schweiz AG
  • Olympus Canada, Inc.
  • Olympus Scientific Solutions Americas, Inc.
  • Olympus (Guangzhou) Industrial Ltd.
  • Olympus Lithuania UAB
  • Olympus Latvia SIA
  • Olympus Finance UK Ltd.


  • CONMED Corporation
  • Stryker Corporation
  • Mauna Kea Technologies SA Class O
  • Merit Medical Systems, Inc.
  • IntroMedic Co., Ltd.
  • Cantel Medical Corp.
  • STERIS Plc
  • Getinge AB Class B
  • Cooper Companies, Inc.
  • Check-Cap Ltd.
  • Kinko Optical Co. Ltd.
  • Motus GI Holdings, Inc.
  • Apollo Endosurgery, Inc.
  • Bruker Corporation
  • Baker Hughes Company Class A
  • Baker Hughes Company Class A
  • Fluidigm Corporation
  • Intersect ENT Inc
  • Intuitive Surgical, Inc.
  • Vuzix Corporation
Last Updated on 6 Dec, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media